nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxyphencyclimine—CHRM3—epilepsy syndrome	0.329	0.371	CbGaD
Oxyphencyclimine—CHRM1—epilepsy syndrome	0.307	0.346	CbGaD
Oxyphencyclimine—CHRM2—epilepsy syndrome	0.251	0.283	CbGaD
Oxyphencyclimine—Biperiden—CHRNA2—epilepsy syndrome	0.000895	0.0973	CrCbGaD
Oxyphencyclimine—Hexylcaine—SCN3A—epilepsy syndrome	0.000761	0.0827	CrCbGaD
Oxyphencyclimine—Cycrimine—CHRM1—epilepsy syndrome	0.000634	0.0689	CrCbGaD
Oxyphencyclimine—Oxyphenonium—CHRM3—epilepsy syndrome	0.00054	0.0587	CrCbGaD
Oxyphencyclimine—Hexylcaine—SCN1A—epilepsy syndrome	0.000535	0.0581	CrCbGaD
Oxyphencyclimine—Oxyphenonium—CHRM1—epilepsy syndrome	0.000504	0.0548	CrCbGaD
Oxyphencyclimine—Hexylcaine—SCN2A—epilepsy syndrome	0.000471	0.0512	CrCbGaD
Oxyphencyclimine—Biperiden—CHRM1—epilepsy syndrome	0.000392	0.0426	CrCbGaD
Oxyphencyclimine—Procyclidine—CHRM3—epilepsy syndrome	0.000391	0.0424	CrCbGaD
Oxyphencyclimine—Procyclidine—CHRM1—epilepsy syndrome	0.000364	0.0396	CrCbGaD
Oxyphencyclimine—Trihexyphenidyl—CHRM3—epilepsy syndrome	0.000357	0.0388	CrCbGaD
Oxyphencyclimine—Trihexyphenidyl—CHRM1—epilepsy syndrome	0.000333	0.0362	CrCbGaD
Oxyphencyclimine—Glycopyrrolate—CHRM3—epilepsy syndrome	0.00033	0.0358	CrCbGaD
Oxyphencyclimine—Oxybutynin—CHRM3—epilepsy syndrome	0.000327	0.0356	CrCbGaD
Oxyphencyclimine—Biperiden—CHRM2—epilepsy syndrome	0.00032	0.0348	CrCbGaD
Oxyphencyclimine—Glycopyrrolate—CHRM1—epilepsy syndrome	0.000307	0.0334	CrCbGaD
Oxyphencyclimine—Oxybutynin—CHRM1—epilepsy syndrome	0.000305	0.0332	CrCbGaD
Oxyphencyclimine—Procyclidine—CHRM2—epilepsy syndrome	0.000297	0.0323	CrCbGaD
Oxyphencyclimine—Trihexyphenidyl—CHRM2—epilepsy syndrome	0.000272	0.0296	CrCbGaD
Oxyphencyclimine—Glycopyrrolate—CHRM2—epilepsy syndrome	0.000251	0.0273	CrCbGaD
Oxyphencyclimine—Oxybutynin—CHRM2—epilepsy syndrome	0.000249	0.0271	CrCbGaD
Oxyphencyclimine—Biperiden—CYP2D6—epilepsy syndrome	0.000146	0.0159	CrCbGaD
Oxyphencyclimine—Oxybutynin—CYP2D6—epilepsy syndrome	0.000114	0.0124	CrCbGaD
Oxyphencyclimine—Biperiden—ABCB1—epilepsy syndrome	0.000105	0.0114	CrCbGaD
Oxyphencyclimine—CHRM3—Metabolism—ABCG2—epilepsy syndrome	2.01e-05	0.000193	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—AVP—epilepsy syndrome	2e-05	0.000192	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.99e-05	0.00019	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CX3CR1—epilepsy syndrome	1.98e-05	0.00019	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—CYP2C19—epilepsy syndrome	1.96e-05	0.000188	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.96e-05	0.000188	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—CYP11A1—epilepsy syndrome	1.95e-05	0.000187	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CHRM2—epilepsy syndrome	1.95e-05	0.000186	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.95e-05	0.000186	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.95e-05	0.000186	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CHRM2—epilepsy syndrome	1.94e-05	0.000186	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CX3CL1—epilepsy syndrome	1.94e-05	0.000186	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—BDKRB1—epilepsy syndrome	1.94e-05	0.000186	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.92e-05	0.000184	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.92e-05	0.000184	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—CDC42—epilepsy syndrome	1.9e-05	0.000182	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—CDC42—epilepsy syndrome	1.9e-05	0.000182	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—GABBR1—epilepsy syndrome	1.89e-05	0.000181	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—GABBR1—epilepsy syndrome	1.89e-05	0.000181	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—CDC42—epilepsy syndrome	1.88e-05	0.00018	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—GABBR1—epilepsy syndrome	1.87e-05	0.000179	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—AVP—epilepsy syndrome	1.84e-05	0.000176	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—AVP—epilepsy syndrome	1.84e-05	0.000176	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—AVP—epilepsy syndrome	1.82e-05	0.000174	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—HRH3—epilepsy syndrome	1.82e-05	0.000174	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—HRH3—epilepsy syndrome	1.81e-05	0.000173	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—HRH3—epilepsy syndrome	1.79e-05	0.000172	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—OPRM1—epilepsy syndrome	1.79e-05	0.000171	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—OPRM1—epilepsy syndrome	1.78e-05	0.000171	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—OPRM1—epilepsy syndrome	1.77e-05	0.000169	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—CYP2D6—epilepsy syndrome	1.76e-05	0.000168	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.72e-05	0.000165	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—CCR5—epilepsy syndrome	1.72e-05	0.000165	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.7e-05	0.000163	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	1.69e-05	0.000162	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.69e-05	0.000162	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CCR3—epilepsy syndrome	1.68e-05	0.000161	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.68e-05	0.000161	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—ADRA2A—epilepsy syndrome	1.67e-05	0.00016	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—BCHE—epilepsy syndrome	1.67e-05	0.00016	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	1.67e-05	0.00016	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.67e-05	0.00016	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	1.65e-05	0.000158	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.65e-05	0.000158	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—NPY—epilepsy syndrome	1.64e-05	0.000157	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—ATP2A2—epilepsy syndrome	1.64e-05	0.000157	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	1.62e-05	0.000156	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.62e-05	0.000156	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	1.6e-05	0.000153	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—AGT—epilepsy syndrome	1.6e-05	0.000153	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—SLC2A1—epilepsy syndrome	1.59e-05	0.000152	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	1.59e-05	0.000152	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	1.59e-05	0.000152	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	1.59e-05	0.000152	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	1.59e-05	0.000152	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	1.59e-05	0.000152	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	1.58e-05	0.000152	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	1.58e-05	0.000152	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	1.58e-05	0.000152	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	1.58e-05	0.000152	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	1.58e-05	0.000152	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	1.58e-05	0.000151	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PLCB1—epilepsy syndrome	1.57e-05	0.000151	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—TH—epilepsy syndrome	1.57e-05	0.00015	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	1.57e-05	0.00015	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	1.57e-05	0.00015	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	1.57e-05	0.00015	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	1.57e-05	0.00015	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	1.57e-05	0.00015	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	1.57e-05	0.00015	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	1.56e-05	0.00015	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	1.55e-05	0.000148	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.53e-05	0.000147	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	1.53e-05	0.000146	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.51e-05	0.000145	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.48e-05	0.000142	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	1.48e-05	0.000141	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	1.48e-05	0.000141	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.47e-05	0.000141	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	1.47e-05	0.000141	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	1.47e-05	0.000141	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.46e-05	0.00014	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	1.46e-05	0.00014	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	1.46e-05	0.00014	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	1.45e-05	0.000139	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	1.45e-05	0.000139	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	1.44e-05	0.000137	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—SST—epilepsy syndrome	1.44e-05	0.000137	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	1.44e-05	0.000137	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	1.44e-05	0.000137	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	1.43e-05	0.000137	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	1.43e-05	0.000137	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—SST—epilepsy syndrome	1.43e-05	0.000137	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	1.42e-05	0.000136	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	1.42e-05	0.000136	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	1.42e-05	0.000136	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—SST—epilepsy syndrome	1.42e-05	0.000136	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	1.42e-05	0.000136	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.41e-05	0.000135	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	1.4e-05	0.000135	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	1.4e-05	0.000134	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	1.4e-05	0.000134	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	1.39e-05	0.000134	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.39e-05	0.000133	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	1.38e-05	0.000132	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	1.35e-05	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.35e-05	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	1.35e-05	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	1.35e-05	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	1.35e-05	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.34e-05	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	1.34e-05	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	1.34e-05	0.000128	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.34e-05	0.000128	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	1.33e-05	0.000128	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	1.33e-05	0.000128	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.33e-05	0.000128	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	1.33e-05	0.000127	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.33e-05	0.000127	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	1.32e-05	0.000127	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	1.32e-05	0.000127	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.32e-05	0.000127	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	1.32e-05	0.000126	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	1.32e-05	0.000126	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	1.32e-05	0.000126	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	1.32e-05	0.000126	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—HMOX1—epilepsy syndrome	1.31e-05	0.000125	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	1.31e-05	0.000125	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	1.31e-05	0.000125	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	1.3e-05	0.000125	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	1.29e-05	0.000124	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—CAT—epilepsy syndrome	1.29e-05	0.000124	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	1.29e-05	0.000123	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	1.28e-05	0.000122	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—ABCB1—epilepsy syndrome	1.26e-05	0.00012	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	1.25e-05	0.00012	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	1.25e-05	0.00012	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	1.24e-05	0.000119	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	1.23e-05	0.000118	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	1.23e-05	0.000118	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	1.22e-05	0.000117	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	1.22e-05	0.000117	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	1.22e-05	0.000116	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	1.21e-05	0.000116	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	1.2e-05	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	1.2e-05	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	1.2e-05	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	1.19e-05	0.000114	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	1.19e-05	0.000114	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	1.18e-05	0.000113	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—GPX1—epilepsy syndrome	1.17e-05	0.000112	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	1.14e-05	0.000109	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	1.13e-05	0.000109	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	1.13e-05	0.000108	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	1.12e-05	0.000108	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	1.12e-05	0.000108	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	1.12e-05	0.000108	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	1.12e-05	0.000107	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	1.11e-05	0.000107	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	1.11e-05	0.000106	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	1.09e-05	0.000104	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	1.08e-05	0.000104	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	1.07e-05	0.000103	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	1.03e-05	9.85e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	1.03e-05	9.82e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—AGT—epilepsy syndrome	1.02e-05	9.81e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	1.02e-05	9.73e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—APOE—epilepsy syndrome	1e-05	9.61e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	1e-05	9.58e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	9.97e-06	9.55e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	9.97e-06	9.55e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	9.95e-06	9.53e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	9.94e-06	9.52e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	9.92e-06	9.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	9.88e-06	9.46e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	9.84e-06	9.42e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	9.82e-06	9.41e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	9.62e-06	9.21e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	9.59e-06	9.18e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	9.51e-06	9.11e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	9.49e-06	9.09e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	9.48e-06	9.08e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	9.39e-06	8.99e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	9.25e-06	8.86e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	9.22e-06	8.83e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	9.13e-06	8.75e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	9.05e-06	8.67e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	9.03e-06	8.64e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	8.94e-06	8.56e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—POMC—epilepsy syndrome	8.62e-06	8.25e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	8.6e-06	8.24e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	8.59e-06	8.23e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	8.57e-06	8.21e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	8.56e-06	8.2e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	8.49e-06	8.13e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	8.48e-06	8.12e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	8.42e-06	8.06e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	8.39e-06	8.03e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	8.31e-06	7.96e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	8.25e-06	7.9e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	8.22e-06	7.87e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	8.14e-06	7.8e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	7.94e-06	7.6e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	7.91e-06	7.58e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	7.91e-06	7.57e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	7.88e-06	7.55e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—ALB—epilepsy syndrome	7.86e-06	7.53e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	7.84e-06	7.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	7.8e-06	7.47e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	7.23e-06	6.92e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	7.21e-06	6.9e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	7.14e-06	6.84e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	7.07e-06	6.78e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	7.05e-06	6.75e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	6.98e-06	6.69e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PTGS2—epilepsy syndrome	6.88e-06	6.58e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	6.39e-06	6.12e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	6.37e-06	6.1e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	6.31e-06	6.04e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	5.94e-06	5.68e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	5.92e-06	5.67e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	5.86e-06	5.61e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	5.82e-06	5.57e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	5.8e-06	5.56e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	5.75e-06	5.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.4e-06	5.17e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	5.39e-06	5.16e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	5.35e-06	5.13e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	5.34e-06	5.11e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	5.33e-06	5.11e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	5.28e-06	5.06e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	5.2e-06	4.98e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	5.18e-06	4.96e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	5.13e-06	4.92e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	5.06e-06	4.84e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	5.04e-06	4.83e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	4.99e-06	4.78e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	4.91e-06	4.7e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	4.89e-06	4.68e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	4.84e-06	4.64e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	4.66e-06	4.47e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	4.65e-06	4.45e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	4.6e-06	4.41e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	4.54e-06	4.35e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	4.53e-06	4.34e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	4.48e-06	4.29e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—AKT1—epilepsy syndrome	3.46e-06	3.31e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	2.9e-06	2.78e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	2.89e-06	2.77e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	2.86e-06	2.74e-05	CbGpPWpGaD
